Literature DB >> 16958428

Intense accumulation of gallium-67 citrate in pancreatic endocrine tumor.

Rieko Watanabe1, Harunao Iizuka, Kyoichi Kaira, Takanori Mori, Atsushi Takise, Jun Ito, Atsushi Motegi, Yasuhiro Onozato, Hiroshi Ishihara.   

Abstract

We report intense accumulation of gallium-67 (Ga-67) citrate in a pancreatic endocrine tumor. A 69-year-old woman was admitted because of cough, fever, and weight loss. An abdominal enhanced computed tomography (CT) scan revealed a large tumor located between the liver and pancreas as well as swollen paraaortic lymph nodes. Whole-body scintigraphy with Ga-67 revealed intense accumulation in the upper abdomen corresponding to the mass, as well as in the midabdomen and the mediastinal lesion. Percutaneous needle biopsy was performed, and the diagnosis was adenocarcinoma of the pancreas. The patient's condition deteriorated, and she died 2 months after admission. The pathological examination at autopsy revealed a pancreatic endocrine tumor. No report has described findings of Ga-67 citrate scintigraphy of pancreatic endocrine tumors. Pancreatic endocrine tumor should be included in a differential diagnosis when such scintigraphic findings are encountered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958428     DOI: 10.1007/s11604-006-0043-0

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  7 in total

1.  Intense accumulation of Ga-67 citrate in solid and cystic tumors of the pancreas.

Authors:  Tamaki Ichikawa; Hiroki Takenaka; Wakako Yamamoto; Hideharu Sugimoto; Osamu Tanaka
Journal:  Clin Nucl Med       Date:  2002-09       Impact factor: 7.794

2.  Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort.

Authors:  J A Madura; O W Cummings; E A Wiebke; T A Broadie; R L Goulet; T J Howard
Journal:  Am Surg       Date:  1997-07       Impact factor: 0.688

3.  Avid accumulation of Ga-67 citrate in adenocarcinoma of pancreas.

Authors:  M Kudo; K Ikekubo; M Hino; A Todo
Journal:  Clin Nucl Med       Date:  1989-11       Impact factor: 7.794

4.  MRI of pancreatic neuroendocrine tumours.

Authors:  N J Owen; S A Sohaib; P D Peppercorn; J P Monson; A B Grossman; G M Besser; R H Reznek
Journal:  Br J Radiol       Date:  2001-10       Impact factor: 3.039

Review 5.  Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.

Authors:  E Bombardieri; E Seregni; C Villano; A Chiti; E Bajetta
Journal:  Q J Nucl Med Mol Imaging       Date:  2004-06       Impact factor: 2.346

Review 6.  Mechanism of gallium-67 accumulation in tumors.

Authors:  M F Tsan; U Scheffel
Journal:  J Nucl Med       Date:  1986-07       Impact factor: 10.057

7.  Intense Ga-67 uptake in adenosquamous carcinoma of the pancreas.

Authors:  I Kuji; H Sumiya; J Taki; K Nakajima; K Yokoyama; S Kinuya; K Kinuya; A Ichikawa; S Konishi; T Michigishi; N Tonami
Journal:  Ann Nucl Med       Date:  1997-02       Impact factor: 2.668

  7 in total
  2 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  The role of nuclear imaging in multiple endocrine neoplasia 1 (MEN 1).

Authors:  Brian Wosnitzer; Ramesh Gadiraju
Journal:  Radiol Case Rep       Date:  2015-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.